Skip to main content

Table 1 Study population – main characteristics

From: Exploring the gut microbiota in patients with pre-diabetes and treatment naïve diabetes type 2 - a pilot study

Characteristics

Type 2 Diabetesa,b

Pre-Type 2 Diabetesa,b

Healthya,b

LUMI-Seq (n = 16)

131-plex (n = 18)

LUMI-Seq (n = 22)

131-plex (n = 22)

LUMI-Seq (n = 48)

131-plex (n = 38)

Male/female (n)

13/3

14/4

12/10

13/9

12/36

8/30

Age, median

64 (54–72)

64 (53–71)

67 (53–74)

66 (53–74)

31 (26–50)

40 (26–51)

BMI, median

28 (26–32)

28 (26–33)

30 (27–34)

30 (26–34)

23 (21–25)

23 (22–25)

HbA1c, %, median

6.8 (6.6–7.2)

6.8 (6.6–7.6)

6.1 (6.1–6.2)

6.1 (6.0–6.2)

5.2 (5.0–5.5)

5.2 (5.0–5.5)

F-cal, mg/kg, median

31 (12–68)

31 (13–61)

50 (32–119)

46 (32–89)

27 (15–55)

23 (14–45)

  1. The characteristics of the participants in each of the study groups, analyzed and included in the LUMI-Seq™ and GA-map® 131-plex data analysis (the 25th and 75th percentiles are shown in parentheses)
  2. aSamples from 16 T2D, 22 pre-T2D and 48 healthy were analyzed with LUMI-Seq™
  3. bSamples from 18 T2D, 22 pre-T2D and 38 healthy were analyzed with the GA-map® 131-plex